Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Research Funding » Israeli Consortium Launches Patient Sequencing Study to Uncover COVID-19 Genetic Risk Factors

Israeli Consortium Launches Patient Sequencing Study to Uncover COVID-19 Genetic Risk Factors

Apr 10, 2020
|
staff reporter

NEW YORK –A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatment methods.

Consortium partners include the Israel Ministry of Health, the Israel Innovation Authority, Sourasky (Ichilov) Medical Center, Rambam Health Care Campus, and startup company Geneyx, which offers next-generation sequencing data analysis, interpretation, reporting, and storage products and services.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Breathe It Out

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

The Next Batch

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Switch for the Second

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.

Science Reviews How Non-Genetic DNA Features Expand Utility of Liquid Biopsies, Presents Study of Enzymes in DNA Methylation

In Science this week: review discusses advances in liquid biopsies, and more.

Apr
13
Featured Webinar

An Opportunity Arises from the Pandemic: The Promise of Targeted NGS for SARS-CoV-2 Detection

Sponsored by
Beckman Coulter Life Sciences

Mitigation of the SARS-CoV-2 pandemic will continue to require innovative solutions. This webinar will outline how Fry Laboratories rapidly redeployed a next-generation sequencing (NGS) pipeline originally created for the detection and identification of bacterial, eukaryotic, and fungal infections in response to SARS-CoV-2.

Apr
21
Featured Webinar

Single-cell Multiomics Analysis of Clonal Evolution in Myeloid Malignancies

Sponsored by
Mission Bio

This webinar, the first in a “Meet the Authors” series sponsored by Mission Bio, will discuss the application of single-cell analysis to decipher clonal evolution across several stages of disease development in myeloid malignancies. 

Apr
22
Featured Webinar

Single-Cell Genomics Decodes the Developing Human Immune System

Sponsored by
10x Genomics

The human immune system is extremely complex, comprised of multiple cell types and states interacting in myriad ways to produce diverse cellular ecosystems.

Apr
23
Featured Webinar

Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity

Sponsored by
Isoplexis

Recent advances in single-cell technologies have provided unprecedented -omic-level insights into cellular heterogeneity and function. 

What's Popular?

In Sequencing

  1. Long-Read Genome Assemblies Have 'Blind Spots' for Structural Variant Detection

    Premium

  2. 10x Genomics, Bio-Rad Laboratories Subsidiary Celsee Headed to Trial in Single-Cell IP Suit

  3. Singapore Precision Medicine Program to Analyze Genetics of 150K Citizens

  4. Microbial Fingerprints, Health Insights Gleaned From Individual Gut Microbiome Dynamics

  5. ­­­­­Intra-Tumor Heterogeneity of Dozens of Cancer Types Characterized

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.